Microsoft Releases GigaPath-Flash, Reporting Roughly 50x Less Compute for Cancer Research

Microsoft Research, the University of Washington and Providence have released GigaPath-Flash and GigaTIME-Flash, two open-weight pathology research models built to lower the cost of studying large cancer cohorts. Microsoft reports that GigaPath-Flash stayed within 3% of the original GigaPath on two whole-slide benchmarks while using roughly 50 times less compute.

Shrinking the cost of a slide

Whole-slide pathology images can exceed a gigapixel, and a model may need to process thousands of image tiles for one slide. That computational load grows when researchers repeatedly extract features, test hypotheses and validate results across large patient groups. The Flash models use a compact ViT-S image encoder distilled from GigaPath’s original billion-parameter encoder.

One smaller backbone, two research jobs

GigaPath-Flash handles whole-slide representation learning. It combines a 22-million-parameter ViT-S tile encoder with a 21-million-parameter LongNet slide encoder. The slide encoder adds context across tile embeddings using dilated attention, which Microsoft says scales linearly with the number of tiles.

GigaTIME-Flash uses that encoder for a different task: predicting multiplex immunofluorescence protein maps from routine H&E tissue images. It replaces GigaTIME’s CNN backbone with the ViT-S encoder and a lightweight convolutional decoder. Microsoft says it matched or improved the original model’s spatial protein prediction quality on its test data and out-of-distribution cohorts spanning brain, breast, colon and lung cancers.

The payoff depends on repeated runs

Microsoft estimates that generating virtual protein maps for 100,000 slides on one A100 GPU would take about seven GPU-days with GigaTIME-Flash, versus about 30 GPU-days with GigaTIME. The estimate assumes about 10,000 tiles per slide and a batch size of 128; slide size, tiling resolution and hardware can change the runtime.

Both models are available with code and weights on Hugging Face under the Apache 2.0 license. Microsoft describes them as early research releases with limited evaluations. They are not intended or validated for diagnosis, prognosis, treatment selection or other patient-care decisions; clinical use would require further multi-institutional and prospective validation.